IP Library Granted Patent US 8,080,490
Granted Patent B2
US 8,080,490 · App. 10/545,738 · Granted Dec 20, 2011

Antimicrobial phosphate glass

Assignee: Schott AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,080,490
App. No.
10/545,738
Granted
Dec 20, 2011
Kind
B2
Abstract

The invention relates to an antimicrobial phosphate glass having the following composition in percent by weight on an oxide basis: P 2 O 5 >66-80 percent by weight; SO 3 0-40 percent by weight; B 2 0 3 0-1 percent by weight; Al 2 O 3 >6.2-10 percent by weight; SiO 2 0-10 percent by weight; Na 2 O>9-20 percent by weight; CaO 0-25 percent by weight; MgO 0-15 percent by weight; SrO 0-15 percent by weight; BaO 0-15 percent by weight; ZnO>0-25 percent by weight; Ag 2 O 0-5 percent by weight; CuO 0-10 percent by weight; GeO 2 0-10 percent by weight; TeO 2 0-15 percent by weight; Cr 2 O 3 0-10 percent by weight; J 0-10 percent by weight; F 0-3 percent by weight.

Claims (86)

1. Antimicrobial acting phosphate glass or glass ceramic in the form of a water-soluble powder, comprising the following composition in percent by weight on an oxide basis

P 2 O 5

>66-80

percent by weight

SO 3

0-16.8

percent by weight

B 2 O 3

0-1

percent by weight

Al 2 O 3

>6.2-10

percent by weight

SiO 2

0-10

percent by weight

Na 2 O

>11.0-20

percent by weight

Li 2 O

0

percent by weight

K 2 O

0

percent by weight

CaO

0-16.8

percent by weight

MgO

0-15

percent by weight

SrO

0-15

percent by weight

BaO

0-15

percent by weight

ZnO

>0-16.8

percent by weight

Ag 2 O

0-5

percent by weight

CuO

0-10

percent by weight

GeO 2

0-10

percent by weight

TeO2

0-15

percent by weight

Cr 2 O 3

0-10

percent by weight

I

0-10

percent by weight

F

0-3

percent by weight.

2. Antimicrobial acting phosphate glass or glass ceramic in accordance with claim 1 , characterized by the fact that the composition comprises less than 0.01 percent by weight B 2 O 3 , preferably being free from B except for impurities.

3. Antimicrobial acting phosphate glass or glass ceramic in accordance with claim 1 , characterized by the fact that the composition comprises 5-16.8 percent by weight CaO.

4. Antimicrobial acting phosphate glass or glass ceramic in accordance with claim 1 , characterized by the fact that the composition comprises 5-16.8 percent by weight ZnO.

5. Antimicrobial acting phosphate glass or glass ceramic in accordance with claim 1 , characterized by the fact that the composition comprises >12- 16.8 percent by weight ZnO.

6. Anticrobial acting phosphate glass or glass ceramic in accordance with claim 1 , characterized by the fact that the composition comprises 0-<1.2 percent by weight Ag 2 O.

7. Antimicrobial acting phosphate glass or glass ceramic in accordance with claim 1 , characterized by the fact that the sum Ag 2 O +CuO +GeO 2 +TeO 2 +Cr 2 O 3 +I+F+ZnO amounts to between 0.01 and 16.8 percent by weight.

8. Antimicrobial acting phosphate glass or glass ceramic in accordance with claim 1 , characterized by the fact that the sum ZnO+CaO+MgO ranges between 10 and 16.8 percent by weight.

9. Antimicrobial acting phosphate glass or glass ceramic in accordance with claim 1 , characterized by the fact that the composition comprises 67-76 percent by weight P 2 O 5 .

10. Antimicrobial acting glass or glass ceramic in accordance with claim 1 , said powder having an average particle size of <20 μm.

11. Antimicrobial acting glass or glass ceramic in accordance with claim 1 , said powder having an average particle size of <10 μm.

12. Antimicrobial acting glass or glass ceramic in accordance with claim 1 , said powder having an average particle size of <5 μm.

13. Antimicrobial acting glass or glass ceramic in accordance with claim 1 , said powder having an average particle size of <1 μm.

14. Antimicrobial acting glass or glass ceramic comprising the glass composition of claim 1 , for use in cosmetic products.

15. Antimicrobial acting glass or glass ceramic comprising the glass composition of claim 1 , for use in deodorant products.

16. Antimicrobial acting glass or glass ceramic comprising the glass composition of claim 1 , for use in medical products and preparations.

17. Antimicrobial acting glass or glass ceramic comprising the glass composition of claim 1 , for use in plastics and polymers.

18. Antimicrobial acting glass or glass ceramic comprising the glass composition of claim 1 , for use in the field of paper hygiene.

19. Antimicrobial acting glass or glass ceramic comprising the glass composition of claim 1 , for use in food.

20. Antimicrobial acting glass or glass ceramic comprising the glass composition of claim 1 , for use in detergents.

21. Antimicrobial acting glass or glass ceramic comprising the glass composition of claim 1 , for use in paints and lacquers.

22. Antimicrobial acting glass or glass ceramic comprising the glass composition of claim 1 , for use in plasters, cements and concrete.

23. Antimicrobial acting glass or glass ceramic comprising the glass composition of claim 1 , for use in products of oral hygiene, dental care, oral care, palatine hygiene, palatine care.

24. Antimicrobial acting phosphate glass or glass ceramic in accordance with claim 1 , said composition having a ratio of Na/Al of between 2:1 and 1:1.

25. Antimicrobial acting phosphate glass ceramic, characterized by the fact that the glass ceramic is obtained from a source glass with a glass composition in accordance with claim 1 .

26. Antimicrobial acting glass or glass ceramic powder comprising the glass ceramic of claim 25 .

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2006
From: FECHNER, JORG HINRICH; ZIMMER, JOSE; SENESCHAL, KARINE
To: SCHOTT AG
Reel/Frame 017689/0459 →
Priority Claims (2)
DE 103 08 186 · Feb 25, 2003 · national
DE 103 41 856 · Sep 9, 2003 · national
Continuity (1)
Related Publication 20060172877A1 · Aug 3, 2006